Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
Launched by UNIVERSITY OF COLORADO, DENVER · Jan 29, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help stroke patients regain movement in their arms using special wearable devices that provide gentle vibrations. Researchers want to find out if these vibrotactile stimulation gloves and shirts can be comfortably worn by patients and if they help improve arm function when used alongside regular rehabilitation therapy. Participants will wear these devices for five hours each day while they are receiving treatment in a rehabilitation unit.
To participate in this trial, individuals must be inpatients at a rehabilitation unit who have experienced a stroke on one side of their body within the last two weeks and have some movement in their arms. They should be expected to stay in the rehabilitation unit for one to three weeks. This study is currently looking for people of all genders aged between 18 and 66. Participants in the trial will be divided into two groups: one will receive the vibrotactile stimulation in addition to regular therapy, while the other will receive only the standard therapy. This trial aims to discover if the new stimulation method can make a difference in recovery for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inpatients at rehabilitation units
- • Unilateral left or right sided ischemic stroke within the previous 2 weeks
- • Have Upper-Extremity Fugl-Meyer scores between 6 and 58
- • Have at least 20 degrees of active shoulder elevation and elbow flexion
- • Expected to stay 1-3 weeks in the rehabilitation unit
- Exclusion Criteria:
- • Under anti-spasticity therapy
- • Patients that are dependent on pacemakers
- • Patients that have defibrillators
- • Have lymphedema or AV fistula for dialysis on an arm
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Broomfield, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported